BJDX Stock Analysis: Buy, Sell, or Hold?
BJDX - Bluejay Diagnostics, Inc. Common Stock
$0.86
-0.07 (-7.46%)
βΌ
5d:
-16.5%
30d:
-28.33%
90d:
-52.49%
WAIT
LOW Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 06, 2026
2d
Get Alerted When BJDX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
βΈοΈ WAIT FOR STABILIZATION: BJDX is down 16.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
βΈοΈ WAIT FOR STABILIZATION: BJDX is down 16.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: BJDX is currently trading at $0.86, which is considered slightly low relative to its 30-day fair value range of $0.79 to $2.02.
Technical Outlook: Technically, BJDX is showing sideways momentum. Immediate support is located at $0.83, while resistance sits at $1.34. Short-term momentum is weak, with the stock down 7.5% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $256.00 (+29667.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BJDX is showing sideways momentum. Immediate support is located at $0.83, while resistance sits at $1.34. Short-term momentum is weak, with the stock down 7.5% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $256.00 (+29667.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$0.79 -
$2.02
Company Quality Score
48/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
72.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BEARISH: Downward momentum (-7.5%)
- BULLISH: Trading 29667.4% below Wall St target ($256.00)
- WARNING: Recommendation downgraded due to -16.5% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$0.79 -
$2.02
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$0.83
Resistance Level
$1.34
Current Trend
Sideways
Technical data as of
Jul 31, 2026
Fundamental Context
Wall Street Target
$256.00
(+29667.4%)
Share & Embed Analysis
Last updated: August 02, 2026 11:00 PM ET
Data refreshes hourly during market hours. Next update: 12:00 AM
Data refreshes hourly during market hours. Next update: 12:00 AM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BJDX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$64 | 55 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$93 | 49 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$384 | 51 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$118 | 52 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$236 | 51 HOLD |